客戶服務區域
Get the updates in your inbox
Subscribe to get the latest news and updates.
No spam. We promise.
Second medical use patents in Brazil
Swiss-type patent claims are vital for incentivizing the development of inventions directed to second medical uses and require special consideration in Brazil.
The thin line between fake and fine
AI-generated designs, lookalike products and social media counterfeits are reshaping the luxury landscape. Explore how high-end brands can defend their identity in a world of fast fakes.
Structure and change: the UPC stretches forth as patent filings remain steady
Some top IP news stories from the last weeks: the European Patent Office (EPO) releases its annual coverage of filing demand as the Unified Patent Court (UPC) reaches across borders.
Everyday IP: Breaking the law without knowing it
Sometimes, Intellectual Property (IP) rights can be infringed by ordinary actions, leading to extraordinary consequences for both the owners and the unintentional violators.
From certificates to courts: litigating second medical use patents
Can further medical uses be eligible for extended protection, and how have Brexit and the UPC affected the situation?
The continuing debate over second medical use patents
Pursuing exclusive rights in Europe for new medical applications of known therapeutics requires close consideration of legal precedent.
Editor's pick
Generative AI and the question of authorship
For the second chapter of this blog miniseries, we examine an issue that has already made considerable waves in the IP world — AI's potential (or lack thereof) for authorship.
When bad packaging is a brand killer
Unremarkable or unappealing packaging hurts your branding and fails to maximize your IP's value. Learn about this potential pitfall and how to avoid it.
® vs. ™: Which trademark symbol should I use and when?
Using the correct trademark symbol at the right time is crucial to protecting your brand identity.
Assessing IP sustainability with the Green Patent Indicator
The Green Patent Indicator is designed to help your organization comply with reporting obligations while directing IP strategy toward greater sustainability and long-term growth.
Discover in...
Patents
Second medical use patents in Brazil
Swiss-type patent claims are vital for incentivizing the development of inventions directed to second medical uses and require special consideration in Brazil.
From certificates to courts: litigating second medical use patents
Can further medical uses be eligible for extended protection, and how have Brexit and the UPC affected the situation?
The continuing debate over second medical use patents
Pursuing exclusive rights in Europe for new medical applications of known therapeutics requires close consideration of legal precedent.
Trademarks
The thin line between fake and fine
AI-generated designs, lookalike products and social media counterfeits are reshaping the luxury landscape. Explore how high-end brands can defend their identity in a world of fast fakes.
Trademarks and global rebranding
Refreshing a corporate image is a high-stakes game; playing it right requires careful consideration of trademarks and other IP rights.
Trademark exhaustion and resale markets
Are there circumstances where trademark owners can object to how their goods are resold? Find out more.
Industry News
Structure and change: the UPC stretches forth as patent filings remain steady
Some top IP news stories from the last weeks: the European Patent Office (EPO) releases its annual coverage of filing demand as the Unified Patent Court (UPC) reaches across borders.
Altering IP: regulations, resolutions and revisions
Catch up with current developments in IP, including the EU Commission's move to shelve draft legislation on SEPs.
Legal fiction: the rise of fake representatives and other IP news
Examining Intellectual Property (IP) stories from recent months allows us to gauge what 2025 might have in store.
